We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$133M
AUM Growth
+$4.83M
Cap. Flow
-$2.41M
Cap. Flow %
-1.81%
Top 10 Hldgs %
72.35%
Holding
636
New
34
Increased
129
Reduced
102
Closed
72

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$965K
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$202K
3
SCTL
Societal CDMO, Inc. Common Stock
SCTL
+$172K
4
OFIX icon
Orthofix Medical
OFIX
+$106K
5
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$86.1K

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$291K
2
NVDA icon
NVIDIA
NVDA
+$219K
3
AAPL icon
Apple
AAPL
+$184K
4
CRM icon
Salesforce
CRM
+$128K
5
LOPE icon
Grand Canyon Education
LOPE
+$123K

Sector Composition

Rank Sector Weight
1 Healthcare 11.94%
2 Financials 4.16%
3 Technology 3.18%
4 Consumer Discretionary 2.81%
5 Communication Services 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMX
476
Himax Technologies
HIMX
$2.03B
$1.62K ﹤0.01%
240
– –
MRK icon
477
Merck
MRK
$322B
$1.55K ﹤0.01%
13
– –
ALV icon
478
Autoliv
ALV
$9.14B
$1.53K ﹤0.01%
18
– –
YMAB
479
DELISTED
Y-mAbs Therapeutics
YMAB
$1.49K ﹤0.01%
220
– –
PTON icon
480
Peloton Interactive
PTON
$2.85B
$1.46K ﹤0.01%
190
– –
OPRX icon
481
OptimizeRx
OPRX
$120M
$1.43K ﹤0.01%
100
– –
MSCI icon
482
MSCI
MSCI
$42.4B
$1.41K ﹤0.01%
3
– –
APTO
483
DELISTED
Aptose Biosciences, Inc.
APTO
$1.39K ﹤0.01%
10
– –
AVGR
484
DELISTED
Avinger, Inc. Common Stock
AVGR
$1.39K ﹤0.01%
127
– –
FTI icon
485
TechnipFMC
FTI
$28.6B
$1.38K ﹤0.01%
+83
New +$1.17K
DELL icon
486
Dell
DELL
$239B
$1.35K ﹤0.01%
25
– –
RH icon
487
RH
RH
$3.33B
$1.32K ﹤0.01%
4
– –
BBBY
488
Bed Bath & Beyond
BBBY
$479M
$1.3K ﹤0.01%
44
– –
ALDX icon
489
Aldeyra Therapeutics
ALDX
$97.1M
$1.3K ﹤0.01%
155
– –
SGMO
490
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.3K ﹤0.01%
1,000
– –
EELV icon
491
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$430M
$1.2K ﹤0.01%
51
– –
ADAP
492
DELISTED
Adaptimmune Therapeutics
ADAP
$1.17K ﹤0.01%
+1,269
New +$1.51K
MSI icon
493
Motorola Solutions
MSI
$72.1B
$1.17K ﹤0.01%
4
– –
DOL icon
494
WisdomTree True Developed International Fund
DOL
$809M
$1.17K ﹤0.01%
25
+1
+4% +$48
ABNB icon
495
Airbnb
ABNB
$90.8B
$1.15K ﹤0.01%
9
– –
NTLA icon
496
Intellia Therapeutics
NTLA
$1.51B
$1.14K ﹤0.01%
28
– –
MHH icon
497
Mastech Digital
MHH
$95.4M
$1.14K ﹤0.01%
115
– –
FDRR icon
498
Fidelity Dividend ETF for Rising Rates
FDRR
$730M
$1.08K ﹤0.01%
26
– –
INFY icon
499
Infosys
INFY
$51B
$1.08K ﹤0.01%
67
-51
-43% -$797
WW
500
DELISTED
WW International
WW
$1.07K ﹤0.01%
160
– –
18 19
20
21 22

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return

HighMark Wealth Management's Q2 2023 Portfolio in Review

As of Q2 2023, HighMark Wealth Management held 636 positions worth $133M, up 3.8% from $128M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

HighMark Wealth Management's Q2 2023 filing shows 34 new, 129 increased, 102 reduced and 72 closed positions. Its largest new stake was Fennec Pharmaceuticals: 3,000 shares worth $26.5K. The largest sale was Amazon, an estimated $291K.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q2 2023 buy was Fennec Pharmaceuticals: 3,000 shares worth $26.5K.
  • HighMark Wealth Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $965K increase.
  • HighMark Wealth Management's biggest Q2 2023 reduction was Amazon, cutting an estimated $291K.
  • HighMark Wealth Management fully exited Salesforce in Q2 2023, selling an estimated $128K.
  • HighMark Wealth Management's ten largest holdings make up 72% of its $133M portfolio in Q2 2023.
  • HighMark Wealth Management opened 34 new positions and closed 72 in Q2 2023.
  • HighMark Wealth Management's portfolio value rose 3.8% quarter-over-quarter to $133M.

Based on HighMark Wealth Management's 13F filing for Q2 2023, filed 26 Jul 2023.